These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 22614711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C, Holden JA, Tripp S, Layfield LJ.
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [Abstract] [Full Text] [Related]

  • 3. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
    Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford RF.
    J Clin Oncol; 2011 Apr 01; 29(10):1239-46. PubMed ID: 21343559
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
    Moreau S, Saiag P, Aegerter P, Bosset D, Longvert C, Hélias-Rodzewicz Z, Marin C, Peschaud F, Chagnon S, Zimmermann U, Clerici T, Emile JF.
    Ann Surg Oncol; 2012 Dec 01; 19(13):4314-21. PubMed ID: 22772867
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO, Kumar S, Wang L, Crotty KA, Arbuckle SM, Mann GJ.
    J Cutan Pathol; 2007 Jun 01; 34(6):448-55. PubMed ID: 17518771
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA.
    Am J Surg Pathol; 2013 Jan 01; 37(1):61-5. PubMed ID: 23026937
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. BRAF mutations in conjunctival melanoma.
    Gear H, Williams H, Kemp EG, Roberts F.
    Invest Ophthalmol Vis Sci; 2004 Aug 01; 45(8):2484-8. PubMed ID: 15277467
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
    Saldanha G, Potter L, Daforno P, Pringle JH.
    Clin Cancer Res; 2006 Aug 01; 12(15):4499-505. PubMed ID: 16899595
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. BRAF mutation detection and identification by cycling temperature capillary electrophoresis.
    Hinselwood DC, Abrahamsen TW, Ekstrøm PO.
    Electrophoresis; 2005 Jun 01; 26(13):2553-61. PubMed ID: 15948220
    [Abstract] [Full Text] [Related]

  • 17. Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas.
    Sviatoha V, Tani E, Ghaderi M, Kleina R, Skoog L.
    Anticancer Res; 2010 Sep 01; 30(9):3267-72. PubMed ID: 20944096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.